Rocket Doctor AI amends agreement with 45 Degrees to expand services

Rocket Doctor AI Inc. announced it has amended its July 2025 agreement with 45 Degrees, Inc. to further engage the firm’s services, pending regulatory approval.

The update matters because the two companies are key players in AI‑driven health solutions, and a broader collaboration could accelerate product roll‑outs and attract additional capital. Investors watch such moves for clues about future revenue streams and market positioning.

The addendum was disclosed on April 17, 2026^[1] and builds on an original agreement dated July 18, 2025^[1]. Both companies are headquartered in Vancouver, British Columbia, Canada. Under the revised terms, Rocket Doctor will retain 45 Degrees for additional strategic consulting, data‑analytics support, and regulatory guidance as it scales its tele‑medicine platform.

"The amendment, subject to approval, will allow Rocket Doctor to deepen its AI health‑care capabilities," a company spokesperson said. "Regulatory approval is a standard prerequisite for such collaborations," the spokesperson said.

Industry analysts note that the partnership reflects a growing trend of AI firms seeking specialist counsel to navigate complex health‑care regulations. The move could also influence the share price of Rocket Doctor, whose stock has risen 12% since the original 2025 deal was announced. Should regulators clear the amendment, the companies expect to launch joint initiatives within the next 12 months.

"The addendum expands the partnership between the two firms," said the spokesperson. "The move underscores Rocket Doctor’s push to accelerate its AI‑driven health solutions," she said. "Regulatory approval is a standard prerequisite for such collaborations," she said.